Viewing Study NCT01672892


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-02-25 @ 5:48 PM
Study NCT ID: NCT01672892
Status: COMPLETED
Last Update Posted: 2022-06-15
First Post: 2012-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Sponsor: Radiation Therapy Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None Endometrial Cancer View
None Gastrointestinal Complications View
None Perioperative/Postoperative Complications View
None Radiation Toxicity View
None Urinary Complications View
None Urinary Tract Toxicity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastrointestinal complications View
None perioperative/postoperative complications View
None radiation toxicity View
None urinary complications View
None urinary tract toxicity View
None endometrial clear cell carcinoma View
None endometrial papillary serous carcinoma View
None stage IA endometrial carcinoma View
None stage IB endometrial carcinoma View
None stage II endometrial carcinoma View
None stage IIIA endometrial carcinoma View
None stage IIIB endometrial carcinoma View
None stage IIIC endometrial carcinoma View
None endometrial adenocarcinoma View
None cervical adenocarcinoma View
None stage IB cervical cancer View
None stage IIA cervical cancer View
None stage IIB cervical cancer View